The arrival of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable excitement within the weight loss community. This novel dual GIP and GLP-1 agonist medication seems to deliver significant improvements in fat reduction compared to existing therapies. Initial clinical trials have s… Read More